SC: CIRP Can Continue Despite Fraudulent Insolvency Plea That Triggered It  ||  Delhi HC: Senior Citizen May Seek Eviction of Daughter-in-Law for Ill-Treatment  ||  Delhi HC: Mere Possession of Visa Does Not Confer an Unconditional Right to Enter India  ||  Delhi HC: Every Insensitive or Objectionable Matrimonial Act Does Not Amount to Cruelty  ||  J&K&L HC: Fake Driving Licence Does Not Exonerate Insurer If Driver Has a Valid Licence  ||  P&H HC: Safety Council Report and CCTV Cannot Be Rejected at Charge Stage for Lack of Proof  ||  Delhi High Court Stays Rs. 213 Crore SAIL Payout to British Firm over Unstamped Arbitral Award  ||  Allahabad HC: Bar Council Cannot Suspend Advocate’s Licence Pending Disciplinary Inquiry  ||  SC: CIRP Need Not Be Set Aside Solely for Fraudulent Filing of Section 9 Plea  ||  Supreme Court: Compromise Decree Passed Without Impleading Necessary Party is Void    

Search Results for Tag : trastuzumab

News

Delhi HC Restrains Reliance from Launching Copy of Roche's Breast Cancer Drug(05.11.2015)

Delhi High Court has restrained Reliance Life Sciences from launching a copy of Swiss Pharma Company Roche's breast cancer drug trastuzumab.

Tags : Delhi High Court , Reliance Life Sciences, breast cancer drug trastuzumab



Delhi High Court to Roche: Can’t Hang on to Breast Cancer Drug For Lifetime(23.02.2017)

Delhi High Court has told Swiss pharma major Roche that it “cannot hang on to” breast cancer drug Trastuzumab, innovated by it, for rest of its life a.....

Tags : Delhi High Court, Trastuzumab, Breast Cancer



Delhi HC Permits Sale and Manufacture of Breast Cancer Drug Trastuzumab(26.04.2016)

Delhi HC has allowed sale and manufacture of breast cancer drug trastuzumab by Biocon and Reliance Life Sciences, with certain restrictions.

Tags : Delhi HC, Breast Cancer Drug , Trastuzumab



Judgments

Delhi High Court to delve into Drug Controller irregularities(25.04.2016)

The Delhi High Court deferred a dispute regarding the development, classification and promotion of bio-similar drugs to 2 June 2016. Brought by Roche .....

Tags : trastuzumab, bio-similar, dcgi, roche



Disclaimer | Copyright 2026 - All Rights Reserved